Physician profile
Daria Kacprzyk
NPI 1811463912
$3,828.58
in general payments reported to CMS, 2019-2025
22 companies · $1,159 in 2025
The $1,159 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $172 · 2022: $264 · 2023: $876 · 2024: $1,357 · 2025: $1,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,392.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $667.83 | 2023-2025 | Apretude |
| Gilead Sciences, INC. | $580.08 | 2021-2025 | Yeztugo |
| Pfizer INC. | $528.01 | 2022-2025 | |
| Novo Nordisk INC | $497.70 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $372.21 | 2021-2025 | |
| Amgen INC. | $223.59 | 2021-2024 | Repatha, Otezla, Krystexxa |
| Lilly USA, LLC | $187.81 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Myriad Women'S Health, INC. | $110.24 | 2023 | Myrisk |
| Merck Sharp & Dohme LLC | $104.65 | 2023-2025 | Gardasil 9, Capvaxive, Gardasil |
| Exact Sciences Corporation | $100.17 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $83.21 | 2024-2025 | Bodyguardian, Wavewriter Alpha Prime 16 |
| Astrazeneca Pharmaceuticals Lp | $62.68 | 2023-2024 | Breztri |
| Biohaven Pharmaceutical Holding Company Ltd. | $60.65 | 2022 | |
| Bausch Health US, LLC | $56.92 | 2023-2025 | Aplenzin |
| Phadia US INC. | $39.49 | 2024-2025 | Immunocap |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $30.87 | 2025 | |
| Axsome Therapeutics, INC. | $27.76 | 2025 | Symbravo |
| Corium, LLC | $26.55 | 2023 | Azstarys |
| Daiichi Sankyo INC. | $19.38 | 2023 | Injectafer |
| Inspire Medical Systems, INC. | $17.32 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2022 | |
| Medtronic, INC. | $15.11 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daria Kacprzyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.